Mind Over Pain: The Neurotech Investment Opportunity
Introduction The global neuromodulation market is projected to reach $13.3 billion by 2028, with pain management applications leading the charge. While these numbers alone should capture investor’s attention, they represent something far more significant: a massive unmet need at the intersection of neurodegenerative diseases and chronic pain. For venture capitalists and startups looking for that […]